The Gauhati Medical College and Hospital (GMCH) has been selected for the second phase clinical testing of India's indigenously developed coronavirus vaccine, Covaxin, Assam Health Minister Himanta Biswa Sarma said.
He said the GMCH would provide all-out support for the second phase clinical testing of Covaxin, which has already shown successful results in phase-one clinical trials.
According to the Minister, till yesterday night, Assam has tested more than 18.22 lakh samples with 79,667 people testing positive for Covid-19. Of the total cases, 56,734 people have recovered from the disease with the recovery rate being 71.2 per cent and mortality rate 0.25 per cent.
Sarma said 197 people have died due to Covid-19 in the state so far. In terms of recovery rate, he said, five states — Delhi, Tamil Nadu, Gujarat, West Bengal and Tripura — were better than Assam..
Jamil Maqsood, the President of the Foreign Affairs Committee of the United Kashmir People's National…
The 6th meeting of the ASEAN-India Trade in Goods Agreement (AITIGA) Joint Committee concluded in…
The US Department of Homeland Security (DHS), on behalf of the Forced Labor Enforcement Task…
A delegation from the Tibetan Parliament-in-Exile (TPiE), led by Speaker Khenpo Sonam Tenphel and accompanied…
On the sidelines of the 2nd India-CARICOM Summit, leaders of the member countries witnessed a…
India's economic growth story has witnessed a remarkable surge in investment spending, with over half…